Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The Runx1-Gata2 axis: epigenetic architecture of lineage fate.

Created on 28 Sep 2026

Authors

Sumit Mallick, Anirban Chakraborty

Published in

Molecular biology reports. Volume 53. Issue 1. Sep 27, 2026. Epub Sep 27, 2026.

Abstract

Cellular identity is established through the precise coordination of transcription factors (TFs) and chromatin remodeling complexes that shape the epigenetic landscape. In hematopoiesis, the interaction between Runx1 and Gata2 transcription factors exemplifies the role of master TFs in direct lineage specification and self-renewal. In this review, we have consolidated recent findings on the epigenetic regulation of the master TFs of the Runx1-Gata2 axis, highlighting roles beyond their classical functions as chromatin architects. Gata2 functions as a pioneer factor that accesses closed chromatin, while Runx1 participates in reshaping topologically associating domains (TADs) and enhancer-promoter interactions, recruiting effectors such as chromodomain helicase DNA-binding protein 7 (CHD7) and ten-eleven translocation (TET) enzymes. Disruptions to this axis, including hypermethylation, enhancer hijacking, or haploinsufficiency, lead to an "epigenetic addiction" in myeloid malignancies, promoting the development of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). We have discussed the recent research on emerging therapeutic strategies, such as epigenetic editing and super-enhancer targeting, which aim to restore proper chromatin architecture in malignant clones.

PMID:
42801378
Bibliographic data and abstract were imported from PubMed on 28 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement